Christeen Moburg

Christeen Moburg

Company: Sangamo Therapeutics

Job title: Director Patient Advocacy


Development of Leriglitazone in Rare Neurodegenerative Diseases 1:50 pm

Read more

day: Day Two

Patient Engagement Throughout the Drug Development Process in Genomic Medicines 1:20 pm

• Emphasizing the importance of early engagement for clinical trial recruitment • How to design a compelling engagement process in order to maximize patient trial retention • A case study of patient engagement for rare metabolic disease clinical trialsRead more

day: Day Two

Panel Discussion: Tackling Ultra-Rare Inborn Errors of Metabolism: Addressing a Huge Unmet Medical Need 3:40 pm

This panel discussion will set to map out the future for ultra-rare inherited metabolic therapeutics. Analyze current and future treatment options and explore how a patient-centric approach to drug development can be utilized through collaborations with advocacy groups. This panel will also address the role of industry-academia collaborations to access and augment novel therapeutic innovations…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.